Recap: Arrowhead Pharma Q4 Earnings

Arrowhead Pharma ARWR reported its Q4 earnings results on Wednesday, November 29, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Arrowhead Pharma missed estimated earnings by 70.0%, reporting an EPS of $-1.02 versus an estimate of $-0.6.

Revenue was down $15.48 million from the same period last year.

Last quarter the company missed on EPS by $0.38 which was followed by a 10.78% drop in the share price the next day.

Here's a look at Arrowhead Pharma's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.58	-0.64	0.44	-0.16
EPS Actual	-0.96	0.45	-0.39	-0.81
Revenue Estimate	48.19M	45.48M	162.52M	50.44M
Revenue Actual	15.82M	146.27M	62.55M	31.57M

To track all earnings releases for Arrowhead Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar